GlaxoSmithKline Clinical Research Study
To apply for this study or to find out more information, come into our main office or contact:
If you are unsure if you meet the requirements, call us today and schedule a screening to determine you eligible.
By meeting these qualifications, you can qualify for the study:
- At least 18 years of age
- ESAs: Currently receiving an ESA for at least 4 weeks (TBC) prior to screening and continuing during the Screening Phase.
- Dialysis: Receiving adequate dialysis for at least 12 weeks prior to randomization, and during the screening/run-in period. Adequate dialysis is defined as follows:
a. HD: A single-pool Kt/V urea of >1.2 [or if Kt/V urea is not available, then urea reduction area (URR) of at least 65%] based on a historical value obtained within the prior three months.
b. PD: A total (peritoneal and kidney) weekly Kt/V urea of >1.7 based on a historical value obtained within the prior three months.
4. Hgb: Mean HemoCue Hgb between 8.0-12.0 g.dL1 (inclusive) as defined in the Hemoglobin Criteria section
5. Comliance with placebo: Any subject who is >80% and <120% compliant with placebo during run-in period (Verification at Day 1 Only)